Celiac Disease Antibody Panel
Celiac disease is a malfunction of the digestive system that presents with an inability to digest gluten, which is found in wheat, barley and oats. When celiac disease is present, the body is unable to absorb nutrients due to damage of the intestinal lining caused by an autoimmune response to the digestion of gluten. The antibodies that are responsible for the intestinal damage are anti-tissue transglutaminase (anti-tTG), which is usually the first level screening test, and anti-gliadin IgG and/or IgA. Symptoms of celiac disease can include malnutrition, abdominal pain, diarrhea, bloating, abdominal distention, joint pain, growth retardation, and failure to thrive in infants. Gluten-free diets will decrease the Anti-tTG and Anti-Gliadin antibody titers in the blood, which brings some relief to the celiac disease symptoms. Those suffering from celiac disease must follow a gluten-free diet so that the damage to the intestines can heal. The incidence of morbidity greatly decreases in these patients when a gluten-free diet is adhered to. Symptoms will return when the gluten-free diet is discontinued. The celiac disease panel usually includes immunoglobulin A (IgA), tissue transglutaminase (tTG) antibodies (IgG and IgA), endomysial antibody IgA, and anti-gliadin antibodies (IgG and IgA). All of these antibodies are usually present in celiac disease patients but can also be present in the disease dermatitis herpetiformis, which is the skin manefestation of celiac disease and may appear without gastrointestinal disease. Screening serum antibody tests are performed first, and bowel biopsies are performed in patients with positive serology results to confirm the diagnosis of celiac disease.
- Aids in diagnosing celiac disease
- Monitors the treatment of celiac disease
- As an aid in evaluation of irritable bowel syndrome and inflammatory bowel disease
- As an aid in evaluation of malabsorption and malnutrition
- As an aid in evaluation of colorectal cancer
- Monitors the adherence to a gluten-free diet
- Aids in determining cause of growth retardation or failure to thrive
Positive:
- Possible celiac disease with decreased IgA: Positive for tissue transglutaminase (tTG IgG), positive Gliadin IgG.
- Possible celiac disease with normal IgA: Positive tTG IgA and/or positive Gliadin IgA
Negative:
- Not likely celiac disease with low/absent IgA: Negative for tissue transglutaminase (tTG IgG) and Negative Gliadin IgG
- Not likely celiac disease with normal total IgA: Negative tTG IgA and Negative Gliadin IgA
Antibody to celiac disease components might be also positive:
- Colorectal cancer patients with a history or unsuspected celiac disease
- Dermatitis herpetiformis
- Rarely positive in some other gastrointestinal diseases associated with inflammation and mucosal damage
Negative (No atnibody detected)
Serum (SST).
Stability
- Ambient: 1-3 days
- Refrigerated: 7 days
- Frozen: 30 days
- Nutr Clin Care. 2005 Apr-Jun;8(2):54-69. [PMID: 16013224]
- Lancet. 1997 Jun 14;349(9067):1755-9. [PMID: 9193393]
- Mol Diagn Ther. 2008;12(5):289-98. [PMID: 18803427]
- Gastroenterol Clin North Am. 2003 Sep;32(3):931-47. [PMID: 14562582]
- Autoimmun Rev. 2010 Sep;9(11):744-9. [PMID: 20547248]
- About Celiac Disease. (1998). Retrieved July 10, 2010, from Celiac Disease Foundation: www.celiac.org Celiac Disease. In Mosby's Dictionary of Medicine, Nursing and Health Professions, 8th Edition (p. 326). St. Louis: Mosby Elsevier (2009).
- Gliadin Antibodies. In Mayo Interpretive Handbook (pp. 354-355). Rochester: Mayo Medical Laboratories (2009). Endomysial Antibodies. In Mayo Interpretive Handbook (pp. 295). Rochester: Mayo Medical Laboratories (2009).